Earnings Performance - Adjusted EPS for Q2 2024 was $1.78, beating the Zacks Consensus Estimate by 16.3% and showing a 25.4% YoY improvement [1] - GAAP EPS for the quarter was $1.46, up 23.7% YoY [1] Revenue Performance - Q2 2024 revenues reached $2.01 billion, a 14% YoY increase, beating the Zacks Consensus Estimate by 2% [2] - On a constant currency basis, revenues grew 15% YoY [2] - Revenue growth was driven by increased da Vinci procedure volume and higher system installations [2] Segment Performance Instruments & Accessories - Segment revenues totaled $1.24 billion, a 16% YoY increase [3] - Growth was driven by a 17% increase in da Vinci procedure volume and 82% growth in Ion procedures [3] - Higher pricing for procedures also contributed to growth, partially offset by unfavorable customer buying patterns [3] Systems - Segment revenues reached $448 million, a 14% YoY increase [4] - The company shipped 341 da Vinci Surgical Systems, up from 331 in the prior-year quarter [4] - 70 da Vinci 5 systems were placed in Q2, following FDA approval in March [4] Services - Segment revenues amounted to $630.8 million, a 10.6% YoY increase [4] Margins - Adjusted gross profit was $14.1 billion, a 16.9% YoY increase, with gross margin at 70%, up 150 bps YoY [5] - Selling, general and administrative expenses totaled $525.3 million, up 13.1% YoY [5] - Research and development expenses totaled $280.1 million, up 14.6% YoY [5] - Adjusted operating income reached $754.1 million, a 22% YoY increase, with operating margin at 37.5%, up 230 bps YoY [5] Financial Position - Cash, cash equivalents, and investments totaled $7.68 billion at the end of Q2, up from $7.32 billion in the previous quarter [6] - Total assets increased to $16.65 billion from $15.83 billion in the prior quarter [6] Market Performance - Shares of Intuitive Surgical rose 6.7% in after-hours trading on June 18 [7] - Year-to-date, shares have risen 31.8%, outperforming the industry's 5.2% gain and the S&P 500's 16.1% gain [8] Industry Comparison - Globus Medical (GMED) has a Zacks Rank 1, with shares rising 35% year-to-date and an estimated long-term growth rate of 12.7% [9] - Hologic (HOLX) has a Zacks Rank 2, with shares rising 8.7% year-to-date and an estimated long-term growth rate of 7.4% [9] - Masimo (MASI) has a Zacks Rank 2, with shares losing 8.3% year-to-date and an estimated growth rate of 9.3% for 2025 [10]

Automation advancements have been incredible, putting the spotlight on the robotics sector as a whole. Indeed, the rise of artificial intelligence has boosted robotics use in manufacturing, healthcare, and e-commerce. This combination has the potential to revolutionize business processes and create vast new possibilities. Many companies invest billions in robotics, and one good example is Tesla (NASDAQ:TSLA).In a recent event, Elon Musk emphasized the untapped economic potential of humanoid robots. He also ...

Intuitive Surgical, Inc. (NASDAQ:ISRG) Q2 2024 Earnings Conference Call July 18, 2024 4:30 PM ET Company Participants Brian King - Head of IR Gary Guthart - CEO Dave Rosa - President Jamie Samath - CFO Conference Call Participants Larry Biegelsen - Wells Fargo Travis Steed - Bank of America Robbie Marcus - JPMorgan David Roman - Goldman Sachs Rick Wise - Stifel Drew Ranieri - Morgan Stanley Adam Maeder - Piper Sandler Richard Newitter - Truist Securities Operator Thank you everyone for standing by and welco ...

Intuitive Surgical, Inc. (ISRG) reported $2.01 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 14.5%. EPS of $1.78 for the same period compares to $1.42 a year ago.The reported revenue represents a surprise of +2.02% over the Zacks Consensus Estimate of $1.97 billion. With the consensus EPS estimate being $1.53, the EPS surprise was +16.34%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to ...

Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $1.78 per share, beating the Zacks Consensus Estimate of $1.53 per share. This compares to earnings of $1.42 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 16.34%. A quarter ago, it was expected that this company would post earnings of $1.40 per share when it actually produced earnings of $1.50, delivering a surprise of 7.14%.Over the last four quarters, the ...

SUNNYVALE, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2024. Q2 Highlights Worldwide da Vinci procedures grew approximately 17% compared with the second quarter of 2023.The Company placed 341 da Vinci surgical systems, compared with 331 in the second quarter of 2023. The second quarter 2024 da Vinci surgica ...

SUNNYVALE, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2024. Q2 Highlights Worldwide da Vinci procedures grew approximately 17% compared with the second quarter of 2023. The Company placed 341 da Vinci surgical systems, compared with 331 in the second quarter of 2023. The second quarter 2024 da Vinci surgic ...

Exhibit 99.1 Contact: Investor Relations (408) 523-2161 INTUITIVE ANNOUNCES SECOND QUARTER EARNINGS SUNNYVALE, CALIF. July 18, 2024 – Intuitive (the "Company") (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2024. Q2 Highlights Q2 Financial Summary • Worldwide da Vinci procedures grew approximately 17% compared with the second quarter of 2023. • The Company placed 341 da Vinci ...

Intuitive Surgical (ISRG) is witnessing strong momentum, with its shares having rallied 26.4% year to date compared with 6.1% growth of the industry. The S&P 500 composite has risen 17.6% during the said time frame.With healthy fundamentals and strong growth opportunities, this Zacks Rank #3 (Hold) company appears to be a solid wealth creator for its investors at the moment.Intuitive Surgical Inc., a Sunnyvale, CA-based company, designs, manufactures and markets the da Vinci surgical system, Ion endoluminal ...

Intuitive Surgical (NASDAQ:ISRG) stock is on the move Thursday after the company’s shares were given a price target increase by Barclays analysts.Barclays analyst Matt Miksic increased the firm’s price target for ISRG stock from $430 per share to $490 per share. That’s a potential upside of 17.5% over its prior closing price. It’s also above the analysts’ consensus price prediction of $426.53 per share.The Barclays analyst reiterated the firm’s “overweight” rating for ISRG stock alongside that price target ...